HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acetylcholinesterase is increased in mouse neuronal and astrocyte cultures after treatment with beta-amyloid peptides.

Abstract
The cellular origin of the acetylcholinesterase (AChE) associated with amyloid plaques in the Alzheimer's disease (AD) brain is unknown. In this study we report that amyloid beta-peptides (Abeta) increased AChE levels in both neuronal and astrocytic primary cultures, supporting the possibility that both neurons and glia may make a direct contribution to the pool of AChE seen around amyloid deposits in the AD brain.
AuthorsJavier Sáez-Valero, Lisa R Fodero, Anthony R White, Colin J Barrow, David H Small
JournalBrain research (Brain Res) Vol. 965 Issue 1-2 Pg. 283-6 (Mar 07 2003) ISSN: 0006-8993 [Print] Netherlands
PMID12591148 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • amyloid beta-protein (25-35)
  • Acetylcholinesterase
Topics
  • Acetylcholinesterase (biosynthesis)
  • Amyloid beta-Peptides (pharmacology)
  • Animals
  • Astrocytes (drug effects, enzymology)
  • Cells, Cultured
  • Cerebral Cortex (cytology, drug effects, physiology)
  • Embryo, Mammalian
  • Mice
  • Mice, Inbred C57BL
  • Neurons (drug effects, enzymology)
  • Peptide Fragments (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: